Pubdate: Sat, 21 May 2016 Source: Chicago Tribune (IL) Copyright: 2016 Chicago Tribune Company Contact: http://www.chicagotribune.com/ Details: http://www.mapinc.org/media/82 Author: Charles A. Bush-Joseph HANDLING PAIN Recent data from the Centers for Disease Control noted over 25,000 deaths in 2015 from prescription opiate overdose with an estimated 1.9 million people dependent on these medications. CDC director Thomas Frieden said, "We know of no other medication routinely used for nonfatal conditions that kills patients so frequently." And despite research showing that the higher the dose of an opioid the greater the risk of overdose and death, an investigation reveals that the opiate manufacturers urged doctors to prescribe stronger doses. Since 1999, OxyContin and other painkillers are responsible for claiming more than 190,000 lives from overdoses. A 2014 study published in JAMA analyzed the association between medical cannabis laws and opioid overdose mortality rates. This study concludes that states with medical cannabis laws had a 24.8 percent lower annual opioid overdose mortality rate in comparison to states without medical cannabis laws, and these reductions in overdose mortality rates generally strengthen each year after implementation of such laws. With these facts in mind, the CDC has issued new guidelines to primary care physicians to dramatically curb the use of prescription opiates. As an orthopedic surgeon, I see many patients who suffer from conditions that traditional treatments or surgeries can't cure. The uncontrolled pain from these failed treatments leads many patients into opiate dependency for simple activities of daily function. Medical cannabis provides physicians another treatment option to manage these difficult problems in a safe and regulated manner. The evolving body of knowledge in the medical literature supports its efficacy in treating non-cancer pain and published studies suggest the effectiveness of medical cannabis as a pain reliever with the added benefits of decreased opiate use. Certainly any therapy that involves medications or compounds that have psychoactive effects warrants concern. That concern must be addressed with regulation to allow the intended benefits to those patients in need with disabling and uncontrolled pain. The Illinois Medical Cannabis Pilot Program is among the most tightly regulated programs in the U.S. and is well-crafted to minimize and prevent abuse of this beneficial therapy. I believe the physician oversight and dispensing regulations allow the safe use of medical cannabis as a treatment for patients suffering from chronic pain, intractable pain and neuropathy. - - Dr. Charles A. Bush-Joseph, professor, department of orthopaedic surgery, Rush University Medical Center, Chicago - --- MAP posted-by: Jay Bergstrom